Hemochromatosis and vitamin C.
Herbert
V
V
D001205:Ascorbic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D002614:Chelating Agents / Q000627:therapeutic use*; D003676:Deferoxamine / Q000627:therapeutic use*; D019587:Dietary Supplements / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006432:Hemochromatosis / Q000150:complications / Q000188:drug therapy*; D006801:Humans
D002614:Chelating Agents; D003676:Deferoxamine; D001205:Ascorbic Acid